Hypotension Prediction Index-guided Hemodynamic Optimization Trial to Reduce Postoperative Acute Kidney Injury (HYT).
HYT
Open-label, Multicenter, Randomized, Controlled Trial of Hemodynamic Optimization Based on the Hypotension Prediction Index (HPI) Compared to Standard Practice in Adult Patients Undergoing Elective Major Abdominal Surgery.
1 other identifier
interventional
958
1 country
26
Brief Summary
MAIN AIM OF THE STUDY To establish whether hemodynamic management guided by the hypotension prediction index (HPI) guided by the administration of intravenous fluids and vasoactive drugs in patients undergoing elective major abdominal surgery reduces the incidence of postoperative moderate-severe acute kidney injury (AKI) in the 30 days after surgery. STUDY DESIGN A low intervention level clinical, blinded, controlled, randomized, multicenter, with daily follow-up of patients until hospital discharge and of postoperative complications and mortality 30 days after surgery will be performed. This is a low-intervention clinical trial comparing standard treatments:
- The drugs used in the investigation are licensed.
- The drugs are used according to the indications contemplated in the technical data sheet and there are published scientific data on their efficacy and safety.
- The complementary diagnostic or follow-up procedures entail a very limited additional risk or burden to the safety of the subjects, which is minimal compared to that of standard clinical practice. STUDY DISEASE Intraoperative hemodynamic monitoring and management in surgical patients undergoing major abdominal surgery. STUDY POPULATION AND TOTAL NUMBER OF PATIENTS The sample of this study consists of patients of both genders, aged over 65 years and/or physical status ASA III or IV, undergoing elective major abdominal surgery (abdominal, urological, gynecological) under general/combined anesthesia (using laparoscopic or open approaches. To detect a 5% absolute reduction (from 10% to 5%) in the primary outcome variable (postoperative AKI up to 30 days) with a sample size ratio of 1%, and an overall type I error rate of 5%, we need 870 patients (435 per arm). Assuming a 10% loss rate, the total amounts to 958 patients, 479 for each group. DURATION OF THE STUDY The total planned duration of the overall study, which includes authorization, recruitment of subjects, and follow-up of subjects until completion of the analysis of the results obtained, is 19 months.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Oct 2022
26 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
October 4, 2022
CompletedFirst Posted
Study publicly available on registry
October 6, 2022
CompletedStudy Start
First participant enrolled
October 8, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 15, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
February 25, 2024
CompletedMarch 1, 2024
February 1, 2024
1.3 years
October 4, 2022
February 29, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Acute kidney injury
The primary outcome is the occurrence of moderate or severe AKI (according to KDIGO Stage 2-3 criteria) within 30 days after surgery. AKI is classified according to the Kidney Disease: Improving Global Outcomes (KDIGO) criteria as follows: Stage 1: Increase in serum creatinine by 1.5 to 1.9 times baseline or increase in serum creatinine by 0.3 mg/dL, or reduction in urine output to \<0.5 mL/kg/hour for 6 to 12 hours. Stage 2: Increase in serum creatinine by 2.0 to 2.9 times baseline, or reduction in urine output to \<0.5 mL/kg/hour for \>12 hours. Stage 3: Increase in serum creatinine to 3.0 times baseline, or increase in serum creatinine to \>4.0 mg/dL or reduction in urine output to \<0.3 mL/kg/hour for \>24 hours, or anuria for \>12 hours, or initiation of renal replacement therapy, or, in patients \<18 years, decrease in estimated glomerular filtration rate (eGFR) to \<35 mL/min/1.73 m2.
7 days after surgery
Secondary Outcomes (7)
Need for renal replacement therapy (RRT)
30 days after surgery
renal replacement therapy (RRT) duration
30 days after surgery
Renal recovery on day 30
30 days after surgery
Mortality
30 days after surgery
Postoperative complications
30 days after surgery
- +2 more secondary outcomes
Study Arms (2)
Hemodynamic prediction index based goal directed hemodynamic therapy
EXPERIMENTALHemodynamic handling will be based hemodynamic prediction index (HPI)
No HPI
NO INTERVENTIONPatients in the control group will be treated according to standard practice.
Interventions
Goal directed Hemodynamic therapy
Eligibility Criteria
You may qualify if:
- Patients over 65 years of age and/or physical condition ASA III or IV.
- Patients who have major elective abdominal surgery indicated: general surgery, urology, gynecology, by laparoscopic or open approaches.
- Patients who sign the informed consent, agreeing to participate in the study.
You may not qualify if:
- Stage 4 or 5 chronic kidney disease (eGFR \< 15 ml/ min)
- Renal transplantation in the previous 12 months
- Glomerulonephritis, interstitial nephritis or vasculitis
- Pre-existing AKI
- Renal replacement therapy (RRT) in the last 90 days
- Participation in another interventional trial investigating a drug/intervention affecting renal function
- Patients with atrial fibrillation
- Patients with known cardiac shunts.
- Patients whose surgical indication is urgent
- Pregnancy or lactation
- Patients expected to die within 30 days.
- Acute myocardial ischemia within the previous 30 days.
- Acute pulmonary edema within the previous 30 days
- Any contraindication to vasoactive or inotropic medication at low doses
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (26)
Hospital Universitario Bellvitge
L'Hospitalet de Llobregat, Barcelona, 08907, Spain
Hospital Universitario de Badajoz
Badajoz, Spain
Hospital Clínic de Barcelona
Barcelona, Spain
Hospital del Mar
Barcelona, Spain
Hospital Universitario de Sant Pau
Barcelona, Spain
Hospital Universitario Moises Brogi
Barcelona, Spain
Hospital Uniuversitario de Basurto
Bilbao, Spain
Hospital Universitario Reina Sofía
Córdoba, Spain
Hospital Universitario Doctor Trueta
Girona, Spain
Hospital San Cecilio
Granada, Spain
Hospital Universitario Virgen de Las Nieves
Granada, Spain
Hospital Universitario Juan Ramón Jimenez
Huelva, Spain
Hospital Universitario de Igualada
Igualada, Spain
Hospital Universitario Jerez de la Frontera
Jerez de la Frontera, Spain
Hospital Universitario de Gran Canaria Doctor Negrín
Las Palmas de Gran Canaria, Spain
Hospital Infanta Leonor
Madrid, Spain
Hospital Universitario Ramón y Cajal
Madrid, Spain
Hospital Universitario Puerta de Hierro
Majadahonda, Spain
Althai Xarxa Universitaria
Manresa, Spain
Hospital Universitario de Donostia
San Sebastián, Spain
Hospital Universitario Marqués de Valdecilla
Santander, Spain
Hospital Clínico Universitario de Santiago
Santiago de Compostela, Spain
Hospital Universitario Virgen de la Macaarena
Seville, Spain
Hospital Universitario Virgen del Rocío
Seville, Spain
Hospital General Universitario de Valencia
Valencia, Spain
Hospital Universitario Ríio Hortega
Valladolid, Spain
Related Publications (3)
Walsh M, Devereaux PJ, Garg AX, Kurz A, Turan A, Rodseth RN, Cywinski J, Thabane L, Sessler DI. Relationship between intraoperative mean arterial pressure and clinical outcomes after noncardiac surgery: toward an empirical definition of hypotension. Anesthesiology. 2013 Sep;119(3):507-15. doi: 10.1097/ALN.0b013e3182a10e26.
PMID: 23835589BACKGROUNDWijnberge M, Geerts BF, Hol L, Lemmers N, Mulder MP, Berge P, Schenk J, Terwindt LE, Hollmann MW, Vlaar AP, Veelo DP. Effect of a Machine Learning-Derived Early Warning System for Intraoperative Hypotension vs Standard Care on Depth and Duration of Intraoperative Hypotension During Elective Noncardiac Surgery: The HYPE Randomized Clinical Trial. JAMA. 2020 Mar 17;323(11):1052-1060. doi: 10.1001/jama.2020.0592.
PMID: 32065827BACKGROUNDRipolles-Melchor J, Carrasco-Sanchez L, Tome-Roca JL, Aldecoa C, Zorrilla-Vaca A, Lorente-Olazabal JV, Colomina MJ, Perez A, Jimenez-Lopez JI, Navarro-Perez R, Abad-Gurumeta A, Monge-Garcia MI; HYT Study Group. Hypotension prediction index guided goal-directed therapy to reduce postoperative acute kidney injury during major abdominal surgery: study protocol for a multicenter randomized controlled clinical trial. Trials. 2024 Apr 29;25(1):288. doi: 10.1186/s13063-024-08113-w.
PMID: 38685032DERIVED
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Javier Ripollés Melchor, MD
Sociedad Española de Anestesiología, Reanimación y Terapéutica del Dolor
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Dr.
Study Record Dates
First Submitted
October 4, 2022
First Posted
October 6, 2022
Study Start
October 8, 2022
Primary Completion
January 15, 2024
Study Completion
February 25, 2024
Last Updated
March 1, 2024
Record last verified: 2024-02
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, SAP, ICF
- Time Frame
- From publication on clinicaltrials.org until 1 year after publication of the results.
- Access Criteria
- under request and Steering Committe review
Upon specific request following the publication of the study